Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 - Verhaak, RG; Hoadley, KA; Purdom, E; Wang, V; Qi, Y; Wilkerson, MD (Cancer Cell, 2010)
et al.